相似文献
1
NewSTEPs: The Establishment of a National Newborn Screening Technical Assistance Resource Center.
Int J Neonatal Screen. 2017 Dec 22;4(1):1. doi: 10.3390/ijns4010001. eCollection 2018 Mar.
2
Expanding Newborn Screening for Pompe Disease in the United States: The NewSTEPs New Disorders Implementation Project, a Resource for New Disorder Implementation.
Int J Neonatal Screen. 2020 Jun 11;6(2):48. doi: 10.3390/ijns6020048. eCollection 2020 Jun.
3
Establishing a National Community of Practice for Newborn Screening Follow-Up.
Int J Neonatal Screen. 2021 Jul 26;7(3):49. doi: 10.3390/ijns7030049.
4
Landscape of Congenital Adrenal Hyperplasia Newborn Screening in the United States.
Int J Neonatal Screen. 2020 Aug 14;6(3):64. doi: 10.3390/ijns6030064.
5
Analyzing Patterns in NewSTEPs Site Review Recommendations: Practical Applications for Newborn Screening Programs.
Int J Neonatal Screen. 2019 Feb 12;5(1):13. doi: 10.3390/ijns5010013. eCollection 2019 Mar.
6
Development of National Newborn Screening Quality Indicators in the United States.
Int J Neonatal Screen. 2019 Sep 12;5(3):34. doi: 10.3390/ijns5030034. eCollection 2019 Sep.
7
Usability of NewSTEPs Data for Assessing the Characteristics of Infants with Newborn Screening Disorders.
Int J Neonatal Screen. 2022 Jul 19;8(3):42. doi: 10.3390/ijns8030042.
8
COVID-19 Pandemic-Related Impacts on Newborn Screening Public Health Surveillance.
Int J Neonatal Screen. 2022 Apr 15;8(2):28. doi: 10.3390/ijns8020028.
9
Newborn screening timeliness quality improvement initiative: Impact of national recommendations and data repository.
PLoS One. 2020 Apr 2;15(4):e0231050. doi: 10.1371/journal.pone.0231050. eCollection 2020.
10
State Legislation, Regulations, and Hospital Guidelines for Newborn Screening for Critical Congenital Heart Defects - United States, 2011-2014.
MMWR Morb Mortal Wkly Rep. 2015 Jun 19;64(23):625-30.
引用本文的文献
1
Dose-intensive therapy (DIT) for infantile Pompe disease: A pilot study.
Mol Genet Metab Rep. 2024 Dec 17;42:101179. doi: 10.1016/j.ymgmr.2024.101179. eCollection 2025 Mar.
2
Infants with Congenital Diseases Identified through Newborn Screening-United States, 2018-2020.
Int J Neonatal Screen. 2023 Apr 13;9(2):23. doi: 10.3390/ijns9020023.
3
Implementation of Newborn Screening for Conditions in the United States First Recommended during 2010-2018.
Int J Neonatal Screen. 2023 Apr 6;9(2):20. doi: 10.3390/ijns9020020.
4
Newborn Screening of Primary Carnitine Deficiency: An Overview of Worldwide Practices and Pitfalls to Define an Algorithm before Expansion of Newborn Screening in France.
Int J Neonatal Screen. 2023 Feb 1;9(1):6. doi: 10.3390/ijns9010006.
5
Early Neonatal Cardiac Phenotype in Hurler Syndrome: Case Report and Literature Review.
Genes (Basel). 2022 Jul 22;13(8):1293. doi: 10.3390/genes13081293.
6
Usability of NewSTEPs Data for Assessing the Characteristics of Infants with Newborn Screening Disorders.
Int J Neonatal Screen. 2022 Jul 19;8(3):42. doi: 10.3390/ijns8030042.
7
A Window of Opportunity for Newborn Screening.
Mol Diagn Ther. 2022 May;26(3):253-261. doi: 10.1007/s40291-022-00590-6. Epub 2022 May 4.
8
Neonatal Screening for Congenital Metabolic and Endocrine Disorders–Results From Germany for the Years 2006–2018.
Dtsch Arztebl Int. 2021 Feb 19;118(7):101-108. doi: 10.3238/arztebl.m2021.0009.
9
Improving quality management of newborn screening in southwest China.
J Int Med Res. 2021 Apr;49(4):3000605211002999. doi: 10.1177/03000605211002999.
10
Landscape of Congenital Adrenal Hyperplasia Newborn Screening in the United States.
Int J Neonatal Screen. 2020 Aug 14;6(3):64. doi: 10.3390/ijns6030064.
本文引用的文献
1
CDC Grand Rounds: Newborn screening and improved outcomes.
MMWR Morb Mortal Wkly Rep. 2012 Jun 1;61(21):390-3.
2
Newborn Screening System Performance Evaluation Assessment Scheme (PEAS).
Semin Perinatol. 2010 Apr;34(2):105-20. doi: 10.1053/j.semperi.2009.12.002.
Zotero 插件